Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The CYP2D6 polymorphism has been studied extensively in association with Parkinson's disease (PD), with no consistent results. Several explanations, such as differences in study design or bias in the selection of the control population, have been offered for these inconsistent results. We designed a case control study nested within a prospective population-based cohort study in which cases and controls were sampled from the same source population. To assess the significance of the CYP2D6 gene in PD, we investigated two mutant alleles, CYP2D6*3 and CYP2D6*4, associated with poor metabolism and the wild type allele in 80 patients with PD and 156 matched controls, frequency matched on age and gender. No differences between cases and controls were found for the poor metabolizer genotype. However, we found that in contrast to earlier reports, the CYP2D6*4 mutant allele frequency was lower in cases as compared to controls, albeit not statistically significant. Our result supports the hypothesis that the CYP2D6 gene is not a major gene responsible for PD.

Original publication




Journal article


Movement disorders : official journal of the Movement Disorder Society

Publication Date





290 - 293


Department of Epidemiology and Biostatistics, Erasmus Medical Center Rotterdam, The Netherlands.


Humans, Parkinson Disease, Cytochrome P-450 CYP2D6, Population Surveillance, Cohort Studies, Prospective Studies, Gene Expression, Genotype, Polymorphism, Genetic, Alleles, Adult, Aged, Aged, 80 and over, Middle Aged, Netherlands, Female, Male